Oba Chizu, Kashiwagi Mitsuru, Tanabe Takuya, Nomura Shohei, Ogino Motoko, Matsuda Takuya, Murata Shinya, Nakamura Michiko, Shirasu Akihiko, Inoue Keisuke, Okasora Keisuke, Tamai Hiroshi
Department of Pediatrics, Hirakata City Hospital, Hirakata, Osaka, Japan.
Department of Child Neurology, Tanabe Children's Clinic, Hirakata, Osaka, Japan.
Pediatr Int. 2018 Mar;60(3):270-275. doi: 10.1111/ped.13492. Epub 2018 Feb 28.
Neurological sequelae occur in 40% of patients with acute encephalopathy (AE). The early prediction of poor outcomes is critical to the initiation of appropriate treatment. The aim of the present study was therefore to elucidate prognostic factors that can be quickly and feasibly evaluated on hospital admission in patients with AE.
We analyzed data from 51 AE patients admitted to Hirakata City Hospital between January 2005 and December 2014. Age at onset, sex, underlying disease, status epilepticus (SE), presence of benzodiazepine-resistant SE (BZD-resistant SE), and basic blood serum parameters on admission were evaluated in relation to each patient's outcome.
On univariate analysis age at onset, BZD-resistant SE, and serum aspartate aminotransferase (AST), alanine aminotransferase, lactate dehydrogenase, and platelet count varied significantly according to outcome. On multivariate analysis age at onset (≤21 months), presence of BZD-resistant SE, and AST (≥46 IU/L) were identified as independent variables associated with poor outcome.
Age at onset, presence of BZD-resistant SE, and AST are associated with a poor prognosis in AE.
40%的急性脑病(AE)患者会出现神经后遗症。早期预测不良预后对于启动适当治疗至关重要。因此,本研究的目的是阐明在AE患者入院时可快速且可行地评估的预后因素。
我们分析了2005年1月至2014年12月期间入住枚方市立医院的51例AE患者的数据。评估了发病年龄、性别、基础疾病、癫痫持续状态(SE)、苯二氮䓬耐药性SE(BZD耐药性SE)的存在情况以及入院时的基本血清参数与每位患者的预后之间的关系。
单因素分析显示,发病年龄、BZD耐药性SE以及血清天冬氨酸转氨酶(AST)、丙氨酸转氨酶、乳酸脱氢酶和血小板计数根据预后有显著差异。多因素分析确定发病年龄(≤21个月)、BZD耐药性SE的存在以及AST(≥46 IU/L)为与不良预后相关的独立变量。
发病年龄、BZD耐药性SE的存在以及AST与AE的不良预后相关。